Pyridoxine-dependent and other pyridoxine-responsive epilepsies-insights into phenotype overlapping and the long-term outcome in a cohort of 21 children. [PDF]
Kravljanac R +2 more
europepmc +1 more source
RASGEF1B suppresses hepatocellular carcinoma through the ALDH7A1/Betaine/SNAI1 metabolic‒epigenetic axis. [PDF]
Guo Z +12 more
europepmc +1 more source
Early-onset pyridoxine-dependent epilepsy due to ALDH7A1 deficiency: the first genetically confirmed case from Palestine. [PDF]
Pujee BK +6 more
europepmc +1 more source
Classical and Emerging Biomarkers in Pyridoxine-Dependent Epilepsy (PDE-ALDH7A1): Implications for Early Diagnosis and Therapeutic Development. [PDF]
Abedrabbo M +3 more
europepmc +1 more source
Uncovering metabolic reprogramming in ovarian and cervical cancers with multi-omics. [PDF]
Ge Y +10 more
europepmc +1 more source
AGPAT3 Regulates Immune Microenvironment in Osteosarcoma via Lysophosphatidic Acid Metabolism. [PDF]
Su S, Zeng Y, Chen J, Dong X.
europepmc +1 more source
Potential of AON therapy targeting AASS: A promising molecular therapy for pyridoxine-dependent epilepsy. [PDF]
Salih MA.
europepmc +1 more source
A novel therapy for pyridoxine-dependent epilepsy due to biallelic pathogenic variants in <i>ALDH7A1</i>: secondary mitochondrial energy deficiency and improvements of neurodevelopmental outcomes on triheptanoin treatment. [PDF]
Ambrose A +5 more
europepmc +1 more source
Editorial: Rare genetic disorders associated with intellectual disability. [PDF]
Salih MA.
europepmc +1 more source
Tellimagrandin II Stimulates Inflammasomes by Causing an Accumulation of 3-Aminopropanal, Which Promotes Apoptosis of Endometriotic Cells While Inhibiting Invasion. [PDF]
Fan W, Zhang Y, Zhao R.
europepmc +1 more source

